Jeffrey A. Knauf - Concepedia

Author

Jeffrey A. Knauf

Memorial Sloan Kettering Cancer Center ORCID

Also Known As

J A Knauf, J. A Knauf, J. A. Knauf, J.A. Knauf, Jeff Knauf, Jeffery A Knauf, Jeffrey A Knauf, Jeffrey A. Knauf, Jeffrey Knauf

365

Publications

12.9K

Citations

H-Index

Concepts

All Affiliations

Memorial Sloan Kettering Cancer Center University of Cincinnati Medical Center University of Cincinnati Cornell University University of Chicago

About

Jeffrey A. Knauf is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	26	4.7K
2	Cell Biology	18	20	3.7K
3	Natural Sciences	2	2	97
4	Engineering	1	1	134
5	Health Sciences	1	1	165

Jeffrey A. Knauf

Publications

12.3K

Citations

H-Index

Page 1

	Year	Citations
High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma. Edna Teruko Kimura, Marina N. Nikiforova, Zhaowen Zhu, PubMed Tumor BiologySomatic MutationSomatic VariantMedicineGenetics	2003	1.5K
Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers Iñigo Landa, Tihana Ibrahimpašić, Laura Boucai, Journal of Clinical Investigation	2016	1.2K
BRAF Mutations in Thyroid Tumors Are Restricted to Papillary Carcinomas and Anaplastic or Poorly Differentiated Carcinomas Arising from Papillary Carcinomas Marina N. Nikiforova, Edna Teruko Kimura, Manoj Gandhi, The Journal of Clinical Endocrinology & Metabolism	2003	1.1K
Deoxyribonucleic Acid Profiling Analysis of 40 Human Thyroid Cancer Cell Lines Reveals Cross-Contamination Resulting in Cell Line Redundancy and Misidentification Rebecca E. Schweppe, Joshua Klopper, Christopher Korch, The Journal of Clinical Endocrinology & Metabolism	2008	563
Mutational Profile of Advanced Primary and Metastatic Radioactive Iodine-Refractory Thyroid Cancers Reveals Distinct Pathogenetic Roles for <i>BRAF, PIK3CA</i> , and <i>AKT1</i> Julio C. Ricarte‐Filho, Mabel Ryder, Dhananjay Chitale, Cancer Research	2009	521
Increased density of tumor-associated macrophages is associated with decreased survival in advanced thyroid cancer Marcia Ryder, Ronald A. Ghossein, Julio C. Ricarte‐Filho, Endocrine Related Cancer Thyroid CancersTumor BiologyTumor-associated MacrophagesHigh DensityOncology	2008	450
Oncogenic AKAP9-BRAF fusion is a novel mechanism of MAPK pathway activation in thyroid cancer Raffaele Ciampi, Jeffrey A. Knauf, Roswitha Kerler, Journal of Clinical Investigation	2005	436
Targeted Expression of BRAFV600E in Thyroid Cells of Transgenic Mice Results in Papillary Thyroid Cancers that Undergo Dedifferentiation Jeffrey A. Knauf, Xiaolan Ma, Eric P. Smith, Cancer Research	2005	416
Molecular genotyping of papillary thyroid carcinoma follicular variant according to its histological subtypes (encapsulated vs infiltrative) reveals distinct BRAF and RAS mutation patterns Michael Rivera, Julio C. Ricarte‐Filho, Jeffrey A. Knauf, Modern Pathology Somatic VariantGeneticsMolecular GenotypingThyroid DiseasePathology	2010	380
Small-molecule MAPK inhibitors restore radioiodine incorporation in mouse thyroid cancers with conditional BRAF activation Debyani Chakravarty, Elmer Santos, Mabel Ryder, Journal of Clinical Investigation Braf ExpressionPathologyTumor BiologyOncologyConditional Braf Activation	2011	378

Page 1